Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056184
Filing Date
2021-11-10
Accepted
2021-11-10 16:10:57
Documents
73
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q grph-10q_20210930.htm   iXBRL 10-Q 4173547
2 EX-31.1 grph-ex311_6.htm EX-31.1 20791
3 EX-31.2 grph-ex312_7.htm EX-31.2 20846
4 EX-32.1 grph-ex321_8.htm EX-32.1 9510
5 EX-32.2 grph-ex322_9.htm EX-32.2 9565
  Complete submission text file 0001564590-21-056184.txt   10833351

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA grph-20210930.xsd EX-101.SCH 71870
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE grph-20210930_cal.xml EX-101.CAL 41429
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE grph-20210930_def.xml EX-101.DEF 257459
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE grph-20210930_lab.xml EX-101.LAB 506171
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grph-20210930_pre.xml EX-101.PRE 403847
11 EXTRACTED XBRL INSTANCE DOCUMENT grph-10q_20210930_htm.xml XML 1513221
Mailing Address 279 EAST GRAND AVENUE, SUITE 430 SOUTH SAN FRANCISCO CA 94080
Business Address 279 EAST GRAND AVENUE, SUITE 430 SOUTH SAN FRANCISCO CA 94080 (650) 484-0886
Graphite Bio, Inc. (Filer) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40532 | Film No.: 211396671
SIC: 2836 Biological Products, (No Diagnostic Substances)